NM_201624.3:c.2069A>G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_201624.3(USP33):c.2069A>G(p.Lys690Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000618 in 1,612,108 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_201624.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 250846Hom.: 1 AF XY: 0.000184 AC XY: 25AN XY: 135582
GnomAD4 exome AF: 0.000657 AC: 959AN: 1459896Hom.: 2 Cov.: 31 AF XY: 0.000638 AC XY: 463AN XY: 726234
GnomAD4 genome AF: 0.000250 AC: 38AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2162A>G (p.K721R) alteration is located in exon 20 (coding exon 19) of the USP33 gene. This alteration results from a A to G substitution at nucleotide position 2162, causing the lysine (K) at amino acid position 721 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at